Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Sell

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Buy

Wall Street Data Solutions Rating

Neutral

B

Equillium, Inc. Common Stock (EQ)

Pharmaceutical Preparations

https://www.equilliumbio.com

Equillium Inc is a biotechnology developing therapies to treat autoimmune and inflammatory disorders. Its pipeline includes itolizumab, a first-in-class antibody targeting the CD6-ALCAM pathway which plays a key role in the modulation of effector T cells - currently in a Ph 3 study for patients with acute graft-versus-host disease and a Ph 1b study for patients with lupus nephritis. EQ101, a first-in-class cytokine inhibitor that selectively targets IL-2, IL-9, and IL-15 is Ph 2 ready and expected to begin enrolling patients in an alopecia areata study in 2H 2022. EQ102, a cytokine inhibitor that selectively targets IL-15 and IL-21, is ready for clinical development and expected to begin enrolling patients in a Ph 1study including patients with celiac disease.

2223 AVENIDA DE LA PLAYA, SUITE 105
LA JOLLA, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

10/12/2018

Market Cap

27,985,276

Shares Outstanding

35,120,000

Weighted SO

35,119,248

Total Employees

N/A

Upcoming Earnings

08/14/2024

Similar Tickers

LYRA --.--%

HOOK --.--%

LIAN --.--%

JSPR --.--%

CINGW --.--%

SABS --.--%

ANEB --.--%

CVKD --.--%

MNPR --.--%

Beta

1.8180

Last Div

0.0000

Range

0.45-3.25

Chg

-0.0199

Avg Vol

333320

Mkt Cap

27985276

Exch

NASDAQ

Country

US

Phone

858 412 5302

DCF Diff

2.4299

DCF

0.0101

Div Yield

0.0000

P/S

0.6566

EV Multiple

-1.9116

P/FV

1.2428

Div Yield %

0.0000

P/E

-3.3519

PEG

-0.1341

Payout

0.0000

Current Ratio

2.0768

Quick Ratio

2.0768

Cash Ratio

0.5482

DSO

59.8757

DIO

0.0000

Op Cycle

59.8757

DPO

12499.1603

CCC

-12439.2847

Gross Margin

0.9969

Op Margin

-0.2279

Pretax Margin

-0.1831

Net Margin

-0.1952

Eff Tax Rate

-0.0641

ROA

-0.1941

ROE

-0.3688

ROCE

-0.4281

NI/EBT

1.0656

EBT/EBIT

0.8036

EBIT/Rev

-0.2279

Debt Ratio

0.0142

D/E

0.0271

LT Debt/Cap

0.0114

Total Debt/Cap

0.0264

Int Coverage

9.8921

CF/Debt

-25.6864

Equity Multi

1.9106

Rec Turnover

6.0960

Pay Turnover

0.0292

Inv Turnover

0.0000

FA Turnover

46.2790

Asset Turnover

0.9944

OCF/Share

-0.4432

FCF/Share

-0.4470

Cash/Share

0.9435

OCF/Sales

-0.3670

FCF/OCF

1.0084

CF Coverage

-25.6864

ST Coverage

-44.6943

CapEx Coverage

-119.4122

Div&CapEx Cov

-119.4122

P/BV

1.2428

P/B

1.2428

P/S

0.6566

P/E

-3.3519

P/FCF

-1.7741

P/OCF

-1.7823

P/CF

-1.7823

PEG

-0.1341

P/S

0.6566

EV Multiple

-1.9116

P/FV

1.2428

DPS

0.0000

Latest Headlines (EST)

The Motley Fool Jun 21, 13:22 VTI Is a Great Choice for Most, but I Like EQAL ETF Even Better GlobeNewswire Inc. Jun 20, 19:59 Leading the world! BJMINING is known as the safest and most efficient cloud mining platform The Motley Fool May 29, 22:29 Why Standard Lithium Stock Sank on Thursday GlobeNewswire Inc. May 22, 05:50 Equinor ASA: Announcement of cash dividend per share in NOK for fourth quarter 2024 GlobeNewswire Inc. May 22, 05:50 Equinor ASA: Annonsering av kontantutbytte per aksje i NOK for fjerde kvartal 2024 The Motley Fool May 17, 15:29 Prediction: 2 Stocks That Will Be Worth More Than Prologis 10 Years From Now GlobeNewswire Inc. May 15, 05:50 Equinor ASA: Eks utbytte fjerde kvartal 2024 i dag – OSE GlobeNewswire Inc. May 15, 05:50 Equinor ASA: Ex. dividend fourth quarter 2024 today – OSE The Motley Fool May 04, 19:10 Do Strong Earnings Results and a Dividend Hike Make Alphabet a Growth Stock to Buy Right Now? GlobeNewswire Inc. May 02, 00:29 Equinor selger Peregrino-feltet for 3,5 milliarder USD GlobeNewswire Inc. May 02, 00:29 Equinor sells the Peregrino field for USD 3.5 billion GlobeNewswire Inc. Apr 30, 04:48 Equinor vil starte andre transje av tilbakekjøpsprogrammet for aksjer for 2025 GlobeNewswire Inc. Apr 30, 04:48 Equinor to commence second tranche of the 2025 share buy-back programme GlobeNewswire Inc. Apr 30, 04:45 Equinor first quarter 2025 results GlobeNewswire Inc. Apr 30, 04:45 Equinors resultater for første kvartal 2025 GlobeNewswire Inc. Apr 21, 22:15 Smackover Lithium’s South West Arkansas Project Receives Special Designation as a Priority Transparency Critical Mineral Project From the Trump Administration Benzinga Apr 09, 21:33 KKR Outbids Competitors To Secure $2.9 Billion Karo Healthcare Takeover The Motley Fool Mar 30, 14:06 The Ultimate Guide to REITs: Strategies to Buy, Hold, and Profit GlobeNewswire Inc. Mar 23, 20:21 Crypto Whales Are Watching These 3 Altcoins – Should You Buy In Too Before the Charts Reset Benzinga Mar 19, 03:10 Hahm Partners PR & Marketing Group in Korea, Pioneering Global Expansion Through AI-Driven Fandom Commerce & PR Innovation

Revenue Product Segmentation